Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
News Menu

News

News

Tue, Mar 26th, 2019
Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of JZP-258 in Adult Narcolepsy Patients with Cataplexy and Excessive Daytime Sleepiness

DUBLIN , March 26, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive top-line results from the global, double-blind, placebo-controlled, randomized-withdrawal,...

JAZZ : 136.54 (-0.28%)
The Vitamin Shoppe® Announces Chief Financial Officer Resignation

SECAUCUS, N.J. , March 26, 2019 /PRNewswire/ -- Vitamin Shoppe, Inc. (NYSE: VSI) (the "Company"), an omni-channel, specialty retailer of nutritional products, today announced that Bill Wafford resigned...

NBH : 14.55 (-0.07%)
NBO : 12.52 (-0.16%)
NBW : 13.10 (-0.23%)
VSI : 7.48 (+0.27%)
Curis Reports Fourth Quarter and Year-End 2018 Financial Results

LEXINGTON, Mass. , March 26, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported...

CRIS : 2.01 (+6.35%)
Colgate Bright Smiles, Bright Futures® Sets its Sights on the Next Billion Smiles

NEW YORK , March 26, 2019 /PRNewswire/ -- After reaching  one billion children  around the world, Colgate announced that it is expanding its oral health education program Bright Smiles,...

CL : 66.92 (+1.00%)
Japan's Ministry of Health, Labour and Welfare Approves CSL Behring Immunoglobulins to Treat Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

TOKYO , March 26, 2019 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that Japan's Ministry of Health, Labour and Welfare has approved two of its immunoglobulin...

CSLLY : 69.4100 (-0.20%)
Astellas Presents Fezolinetant Phase 2b Clinical Trial Results at Endocrine Society's Annual Meeting (ENDO)

TOKYO , March 26, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa , Ph.D., "Astellas") today announced results from a Phase 2b dose-finding study...

ALPMY : 15.6300 (+4.62%)
Mallinckrodt Announces 2019 Investigator Award for Pioneering Efforts in ECP Immunomodulation

STAINES-UPON-THAMES, England , March 26, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today announced the recipient of 2019's Advancing Extracorporeal...

MNK : 21.38 (-1.11%)
MCD : 187.48 (+0.95%)
RegeneRx and Lee's Pharm to Accelerate RGN-259 Development in China

ROCKVILLE, Md. and HONG KONG , March 26, 2019 /PRNewswire/ --  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused...

RGRX : 0.2358 (+7.18%)
Shineco, Inc. Receives Regional Government Merchants Invitation for its Industrial Hemp Business Line

BEIJING , March 26, 2019 /PRNewswire/ -- Shineco, Inc. ("Shineco" or the "Company" ) ( NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized...

TYHT : 1.17 (+15.84%)
Covanta Environmental Solutions Partners with New York State for Second Phase of Pharmaceutical Take-Back Program

MORRISTOWN, N.J. , March 26, 2019 /PRNewswire/ -- Covanta Environmental Solutions, a leading provider of environmental services to the healthcare sector and a wide range of other industries, has...

CVA : 17.63 (+3.40%)
Medical Marijuana, Inc. Subsidiary Phyto Animal Health Announces Participation at NoCo Hemp Expo in Denver

SAN DIEGO , March 26, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , subsidiary Phyto Animal...

MJNA : 0.0620 (-2.52%)
Allergan Acquires Envy Medical, Inc., Adding Skin Resurfacing Dermalinfusion System to Best-in-Class Medical Aesthetics Portfolio

DUBLIN , March 26, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced it has completed the acquisition of Envy Medical, Inc., a privately held...

AGN : 149.39 (+2.08%)
PDL BioPharma to Participate at H.C. Wainwright & Co. Global Life Sciences Conference

INCLINE VILLAGE, Nev. , March 26, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) announces that Dominique Monnet , PDL's president and chief executive officer,...

PDLI : 3.70 (+0.27%)
Neogen reports third quarter results

LANSING, Mich. , March 26, 2019 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that its revenues for the third quarter of its 2019 fiscal year, which ended Feb. 28 , were...

NEOG : 55.50 (-8.31%)
Nutriband Inc.'s Abuse Deterrent Transdermal Technology Patent Granted by European Patent Office

ORLANDO, Fla. , March 26, 2019 /PRNewswire/ -- Nutriband Inc. (OTCQB: NTRB), a Nevada corporation (the "Company"), announced today that the European Patent Office has granted full patent protection...

NTRB : 9.5500 (+1.38%)
Chinese Regulatory Authority [NMPA] Approves IND Application of Oramed's Oral Insulin Capsules

ORMP : 3.39 (+4.63%)
CGEN : 3.84 (+7.26%)
Korea University Medical Center Completes First Varian Halcyon System Treatment in Korea

PALO ALTO, Calif. and SEOUL, South Korea , March 26, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced a 55-year-old male with liver cancer at the Korea University Medical Center Anam...

VAR : 139.12 (+0.30%)
Biocept Broadens Commercial Focus of its Target Selector Liquid Biopsy Platform to Include Urology Market Segment

SAN DIEGO , March 26, 2019 /PRNewswire/ --  Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information...

BIOC : 1.23 (+19.42%)
Natera to Partner with AMAL Therapeutics on Clinical Trial Using Signatera MRD Test to Assess Treatment Response to Colorectal Cancer Vaccine

SAN CARLOS, Calif. , March 26, 2019 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a global leader in cell-free DNA testing, will partner with AMAL Therapeutics on a clinical trial focused...

NTRA : 18.93 (-1.46%)
Actinium Highlights its Participation at the Upcoming Targeted Alpha Therapy International Symposium with Presentations on its AWE Platform, Clinical Programs and New Source of Ac-225 Isotope

NEW YORK , March 26, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), announced today that two oral and four poster presentations related to its Ac-225 or Actinium-225...

ATNM : 0.48 (+2.13%)

Chart of the Day

American Tower Corp (AMT)

The Barchart Chart of the Day belongs to the communication REIT American Tower (AMT). I found the stock by using Barchart to screen for stock having at least a 34+ Weighted Alpha and technical buy signals above 80% (resulted in 167 stocks). I then ...
Read More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar